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Summary Introduction
Dystrophic epidermolysis bullosa (DEB) is a group ofWehave characterized 21mutations in the type VII collagen
inherited skin diseases characterized by blistering andgene (COL7A1) encoding the anchoring ﬁbrils, 18 of which
scarring of the skin after mild trauma. DEB is transmit-were not previously reported, in patients from 15 unrelated
ted in an autosomal dominant or autosomal recessivefamilies with recessive dystrophic epidermolysis bullosa
pattern, both forms showing tissue separation beneath(RDEB). COL7A1 mutations in both alleles were identiﬁed
the basement membrane at the level of the anchoringby screening the 118 exons of COL7A1 and ﬂanking intron
ﬁbrils (AF) (Fine et al. 1991; Bruckner-Tuderman 1993).regions. Fourteen mutations created premature termination
Abnormalities in the number and morphology of AF arecodons (PTCs) and consisted of nonsense mutations, small
the characteristic hallmark in DEB patients’ skin, andinsertions, deletions, and splice-site mutations. A further
the expression of type VII collagen, the major compo-seven mutations predicted glycine or arginine substitutions
nent of AF, is frequently altered (Heagerty et al. 1986;in the collagenous domain of the molecule. Two mutations
Leigh et al. 1988; Bruckner-Tuderman et al. 1989). Wewere found in more than one family reported in this study,
and others have established linkage between the typeand six of the seven missense mutations showed clustering
VII collagen gene (COL7A1) and both dominantwithin exons 72–74 next to the hinge region of the protein.
(DDEB) and recessive (RDEB) forms of DEB with noPatientswhowere homozygous or compound heterozygotes
evidence for locus heterogeneity (Ryyna¨nen et al. 1991;for mutations leading to PTCs displayed both absence or
Al-Imara et al. 1992; Hovnanian et al. 1992; Dunnill etdrastic reduction of COL7A1 transcripts and undetectable
al. 1994a; Naeyaert et al. 1995). A number of COL7A1type VII collagen protein in skin. In contrast,missensemuta-
mutations have now been reported in DDEB patientstions were associated with clearly detectable COL7A1 tran-
(Christiano et al. 1994d, 1995a, 1995b, 1996b) andscripts and with normal or reduced expression of type VII
RDEB patients (Christiano et al. 1993, 1994a, 1995c,collagen protein at the dermo/epidermal junction. Our re-
1996a, 1996b, 1996c; Hilal et al. 1993; Dunnill et al.sults provide evidence for at least two distinct molecular
1994b; Hovnanian et al. 1994; Bruckner-Tuderman etmechanisms underlying defective anchoring ﬁbril formation
al. 1995; Dunnill et al. 1996; Gardella et al. 1996; Shi-in RDEB: one involving PTCs leading to mRNA instability
mizu et al. 1996), conﬁrming the direct implication ofand absence of protein synthesis, the other implicating mis-
this gene in both forms of the disease.sense mutations resulting in the synthesis of type VII colla-
RDEB comprises several forms, the most severe ofgen polypeptidewith decreased stability and/or altered func-
which is the Hallopeau-Siemens type (HS-RDEB; MIMtion. Genotype-phenotype correlations suggested that the
number 226600). HS-RDEB is characterized by general-nature and location of these mutations are important deter-
ized blistering of the skin, leading to mutilating scarringminants of the disease phenotype and showed evidence for
of ﬁngers and toes, ﬂexural contractures, mucosalinterfamilial phenotypic variability.
involvement, and poor prognosis due to malnutrition,
anaemia, infectious complications, and the development
of aggressive squamous-cell carcinoma. In this form ofReceived February 10, 1997; accepted for publication June 30,
RDEB, AF are frequently absent, and immunoﬂuores-1997.
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nill et al. 1996). Other forms of RDEB comprise the tion, or a delayed termination codon have also been
characterized in this clinicaly moderate form of RDEBmitis, the inverse, and the localized types. These do not
share the extreme severity of the HS-RDEB type and (Christiano et al. 1996c; Shimizu H et al. 1996). Re-
cently, two splicing mutations in COL7A1 have beenoften show essentially normal or somewhat decreased
but positive staining at the DEJ, with various abnormali- described in a patient with the localized form of RDEB
(Gardella et al. 1996). Overall, these results indicateties of AF (Bruckner-Tuderman et al. 1990).
COL7A1 is a complex and unusually compact gene that different combinations of COL7A1 mutations are
associated with various clinical phenotypes.consisting of 31,132 bp and 118 exons transcribed into
a 9.2-kb mRNA (Christiano et al. 1994b, 1994c). Type In this study, we systematically screened the COL7A1
gene for mutations in 18 patients from 15 unrelatedVII collagen molecules are homotrimers, each proa1
(VII) polypeptide chain containing a central triple-heli- RDEB families. Sixteen patients were diagnosed as HS-
RDEB, one patient had RDEB mitis, and another patientcal collagenous domain (145 kD in size) ﬂanked by both
a large (145 kD) amino-terminal noncollagenous (NC- had inverse RDEB. COL7A1 mutations were identiﬁed
in both alleles in all these patients. We have character-1) domain and a small (30 kD) carboxy-terminal non-
collagenous (NC-2) domain (Burgeson et al. 1990; ized 21 mutations, 18 of have not previously described.
Fourteen mutations created PTCs, and seven mutationsChristiano et al. 1994b). The collagenous domain con-
sists of a repeating Gly-X-Y sequence that is disrupted predicted glycine or arginine substitutions in the collage-
nous domain. We investigated the consequences of these19 times by noncollagenous regions. The NC-1 domain
consists of submodules with homology to adhesive pro- mutations on COL7A1 transcript and on type VII colla-
gen expression in a majority of these patients. Genotype-teins, including a cartilage matrix–protein motif, nine
ﬁbronectin type III–like domains, and a segment with phenotype correlations were also analyzed in several
families.homology to von Willebrand factor A domain (Chris-
tiano et al. 1992; Gammon et al. 1992). The NC-2 do-
main contains conserved cysteines involved in the forma- Patients and Methods
tion of disulﬁde linkage between type VII collagen
Patientshomotrimers (Greenspan 1993). During ﬁbrillogenesis,
type VII collagen molecules form antiparallel dimers Eighteen patients from 15 unrelated families with
that overlap through their NC-2 domains, which are RDEB were studied, 2 families (11 and 14) having more
subsequently proteolytically cleaved (Bruckner-Tuder- than one affected offspring (two and three, respectively).
man et al. 1995). AF are formed by the lateral aggrega- Families were of French, Pakistani, Portuguese, Spanish,
tion of the collagenous domains of the dimers, and the or Tunisian origin. Consanguinity was known in ﬁve
NC-1 domains are thought to interact both with compo- families (patients 3, 5, 6, 13, and 14). Sixteen patients
nents of the basement-membrane zone and with anchor- presented with severe generalized RDEB (i.e., HS-
ing plaques in the papillary dermis, thus securing the RDEB), whereas one patient (patient 9) was affected
epidermis to the underlying dermis (Burgeson 1993). with inverse RDEB and one patient (patient 12) with
It has been suggested that the nature and/or the loca- mitis RDEB. The diagnosis was based on family history,
tion of mutations in COL7A1 determine the variations clinical examination, and electron-microscopic evalua-
in clinical phenotype, type VII collagen expression, and tion according to criteria as deﬁned by Fine et al. (1991).
AF formation (Hovnanian et al. 1993; Uitto and Chris- Ethical-committee approval was obtained for the study.
tiano 1994). In support of this interpretation, a majority
Immunoﬂuorescence Stainingof mutations reported in HS-RDEB result in premature
termination codons (PTCs) (Uitto et al. 1995), which Indirect immunoﬂuorescence staining was performed
are thought to lead to null alleles through PTC-mediated on cryosections of punch biopsies of skin from upper
mRNA decay (Maquat 1995). In contrast, DDEB has inner thigh, as described elsewhere (Bruckner-Tuderman
been shown to be due to glycine substitutions in the et al. 1989). The primary mouse monoclonal antibody
collagenous domain of the molecule. However, glycine LH7:2 to the NC-1 domain of human collagen VII
substitutions in the collagenous domain of type VII col- (Sigma Immuno Chemicals) was diluted 1:1,000, and
lagen, either present at the homozygous state or com- a ﬂuorescein isothiocyanate–conjugated secondary goat
bined with a PTC, have also been reported in HS-RDEB, anti-mouse antibody (Sigma Immuno Chemicals) was
indicating that some glycine substitutions act in a reces- diluted 1:100. Monoclonal antibody GB3 to laminin 5
sive manner (Christiano et al. 1996b; Dunnill et al. (Valbiotech), diluted 1:100, was also used.
1996; Shimizu et al. 1996). Mutations in COL7A1 have
Standard Electron Microscopy and Immunoelectronalso been described in RDEB mitis, the ﬁrst of which
Microscopy (IEM)was a methionine-to-lysine substitution in the NC-2 do-
main of COL7A1 (Christiano et al. 1993). PTCs associ- Four-millimeter punch biopsies obtained from the in-
ner thigh were processed for standard electron micros-ated with either a glycine substitution, a splice-site muta-
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copy as described by Eady (1985). IEM was performed were mixed and heated to 98C for 5 min, followed by
68C for 1 h, to induce the formation of heteroduplexes.in patients 10, 12, and 14, by use of a preembedding
technique adapted from Prost et al. (1984) and McGrath The PCR products were loaded on a gel containing 10%
acrylamide, 15% formamide, 10% ethylene glycol, andet al. (1993). Immunolabeling was performed with two
primary antibodies: LH7:2 (diluted 1:2) and GB3 (di- 0.5% glycerol-tolerant buffer (USB) and were subjected
to electrophoresis at 500 V for 16 h, as described byluted 1:10). A goat anti-mouse secondary antibody was
used, prepared in one of two ways: either 1 nmol gold Ganguly et al. (1993).
conjugated (Biocell) and diluted 1:3 or peroxidase la-
beled (Biosys) and diluted 1:10. Fixation in Karnovsky Sequence Analysis
reagent was followed by silver enhancement, postﬁxa- PCR products showing abnormal electrophoretic mo-
tion by osmium tetroxide, and embedding. Uncontrasted bility were gel puriﬁed and subjected to direct automated
ultrathin sections were observed under a Jeol 1200 EX sequencing using dideoxy-terminator cycle sequencing
transmission-electron microscope. A biopsy of a surgical and an Applied Biosystems model 373A automated se-
skin sample obtained from breast plastic surgery from quencer. Alternatively, PCR products were ampliﬁed by
a normal subject was used as a control. use of a biotinylated primer, and manual sequencing
was performed by use of a[35S]-dATP and the Sequenase
PCR Ampliﬁcation version 2.0 DNA sequencing kit (USB). All products
Genomic DNA was extracted from peripheral blood were sequenced in the forward and reverse orientations.
leukocytes by use of standard methods. PCR ampliﬁca- Some of the PCR products were subcloned into the
tion of COL7A1 was performed by use of 68 pairs of pGEMT vector (TA cloning kit; Invitrogen), and the
oligonucleotide primers, spanning all 118 exons and plasmid insert was sequenced.
ﬂanking splice sites of the gene. The NC-1 domain (ex-
ons 1–28) was screened by denaturing gradient gel elec- Keratinocyte Culture, RNA Extraction, and Reverse
trophoresis (DGGE) using 21 sets of primers (sequences Transcriptase–PCR (RT-PCR)
are available, on request, from the authors). The collage-
Keratinocytes were cultured from 5-mm punch biop-
nous domain (exons 29–112) and the NC-2 domain
sies obtained from the patients, as described by Rhein-
(exons 113–118) were studied by means of conforma-
wald and Green (1975) and Rochat et al. (1994). Total
tion-sensitive gel electrophoresis (CSGE) using 47 sets
RNA was extracted from conﬂuent cell layers, by use
of primers described by Christiano et al. (in press). The
of the guanidium thiocyanate method described by
conditions for PCR ampliﬁcation consisted of 94C for
Chomczynski and Sacchi (1987). cDNA was generated
4 min, followed by 35 cycles of 94C for 30 s, melting
from total RNA by reverse transcription using random
temperature of the primers for 40 s, and 72C for 30 s
hexanucleotides (Pharmacia Biotech) and Moloney mu-
in a MJ Research PTC-100 thermal cycler. Splice-site
rine leukemia virus reverse transcriptase (Stratagene).
mutations were further investigated by ampliﬁcation of
Exonic primers ﬂanking the mutation were used to am-
reverse-transcribed RNA from keratinocytes by use of
plify and sequence cDNA.
COL7A1 cDNA primers encompassing the exons ﬂank-
ing the mutation (sequences are available, on request,
Northern Blot Analysisfrom the authors).
Keratinocyte total RNA (30 mg) was subjected to elec-
trophoresis on 1% agarose in the presence of formalde-DGGE Analysis
hyde and was transferred to a Pall biodyne B membraneOne primer of each set used for DGGE analysis con-
(Pall BioSupport). The cDNA probes for type VII colla-tained a GC-rich tail of 55–66 bases, to increase muta-
gen K131 (Parente et al. 1991) and for the ubiquitouslytion detection efﬁciency (Shefﬁeld et al. 1989). Denatur-
expressed glyceraldehyde 3-phosphate dehydrogenaseing conditions resulting in optimal resolution were
(GAPDH) gene were radiolabeled with a[32P]-dCTP andselected by use of Lerman’s MELT87 and SQHTX pro-
were used as hybridization probes.grams (Lerman and Silverstein 1987). The ampliﬁcation
products were subjected to electrophoresis on a 6.4%
Restriction-Endonuclease Analysis of Ampliﬁedpolyacrylamide gel containing a linearly increasing de-
Genomic DNAnaturant concentration of 50%–90% parallel to the di-
rection of migration as described by Myers et al. (1987). Ampliﬁed genomic DNA was cleaved with the appro-
priate restriction enzymes (AvaII, BglI, BspMI, BspWI,The gels were run at 160 V and 60C for 3–9 h.
BspHI, BsiEI, BsiYI, DdeI, Fnu4HI, MspI, NlaIII, PstI,
CSGE Analysis ScrFI, StyI, TaqI, and XhoI) according to the manufac-
turer’s recommendations (New England Biolabs andThe primers sets used for CSGE analysis are described
by Christiano et al. (in press). After PCR ampliﬁcation, Boehringer Mannheim) and was analyzed on 2% aga-
rose or 6% PAGE.the products from the patients and a normal subject
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codons 185 and 2610, respectively, resulting in TGA
stop codons; patient 1 had a CrT transition at CAG
glutamine 281, leading to a TAG stop codon; and pa-
tient 11 had a GrT transversion at GGA glycine 2216,
resulting in a TGA stop codon. Patients 2, 9, and 10
presented a CrT transition at CGA arginine codons
578, 236, and 1343, respectively, which had been re-
ported elsewhere (Hovnanian et al. 1994; Dunnill et al.
1996). All these patients were compound heterozygotes,Figure 1 CSGE analysis of PCR-ampliﬁed genomic DNA from
with the second COL7A1 mutation being either a smallseven exons of COL7A1 in RDEB patients. Abnormally migrating
fragments are indicated by arrows. Numbers above the horizontal deletion (patient 1), a splice-site mutation (patient 2),
brackets denote exons; and numbers below the horizontal brackets or a missense mutation (patients 8–12).
denote patients (C Å control). Frameshift mutations resulting in PTCs.—Two small
insertions and one small deletion in the coding region,
creating shifts in the reading frame, were characterized
Genotype Analysis in four unrelated patients. Patients 3 and 4 were homo-
Individuals from families 3, 4, 10, and 11 were geno- zygous for an insertion of C325 and G326 (325insCG) in
typed by use of the microsatellite markers D3S1573 and exon 3, which predicted a TGA stop codon 113 bp
D3S1076 ﬂanking the COL7A1 locus at 3p21 (Chris- downstream of codon 108. Patient 7 was a compound
tiano et al. 1996a). The following primers were used: heterozygote for the insertion of C6527 in exon 80
D3S1573-L, 5-TTCATTTTTGCTTATTAAGATATGC- (6527insC), resulting in a TAA stop codon 337 bp
3; D3S1573-R, 5-CCAGTAAATCACAGGGCTAT- downstream of codon 2176. Patient 1 demonstrated a
3; D3S1076-L, 5-ATTCCCTGCATATGATCCCAA- 7-bp deletion in exon 5, which led to a TGA stop codon
CTG-3; and D3S1076-R, 5- ACCTAAGAGCAATCA- 22 nucleotides downstream of codon 173.
CTTAACTTAG-3 (Christiano et al. 1996a). The PCR- Splice-site mutations.—Four patients (patients 2 and
reaction conditions were as described above, with an 5–7) exhibited intronic splice-site mutations, three of
annealing temperature of 60C. PCR products were sep- which altered the invariant splice-donor or -acceptor
arated on denaturing polyacrylamide gels (Sequagel; Na- sites’ consensus sequences GT and AG. Patient 2 dis-
tional Diagnostics) and were transferred to a Pall bio- played a GrA change at the /1 position of the splice-
dyne B membrane (Pall BioSupport). One PCR primer donor site of intron 5 (682/1GrA). The analysis of RT-
of each set was end-labeled with a[32P]-dCTP by use of PCR products from this patient showed a larger band in
terminal transferase (Boehringer Mannheim) and hy- addition to the band of normal size, the intensities of
bridized to membranes for 2 h at 42C in Church buffer both bands being reduced in comparison with those in
(Church and Gilbert 1984). Membranes were washed the control (ﬁg. 2, lane 2). Direct sequencing of the band
in 2 1 SSC, 0.1% SDS at room temperature and were of normal size showed a normal sequence, whereas se-
exposed to x-ray ﬁlm. quencing of the larger band revealed retention of the
entire intron 5. This change creates a frameshift intro-
ducing a PTC at a TAG codon 33 bp after codon 227Results
(ﬁg. 3a).
The entire coding sequence of the COL7A1 gene and Patient 5 had a CrG substitution changing the variant
ﬂanking intron boundaries were ampliﬁed and screened C residue at position 03 of the splice-acceptor site of
for mutation, by DGGE or CSGE. Representative exam- intron 2. After RT-PCR ampliﬁcation, a band of larger
ples of band shifts detected by CSGE analysis are shown size, in addition to a band of normal size, could be
in ﬁgure 1. Sequencing of variants showing abnormal detected (ﬁg. 2, lane 5). Both bands were reduced in
electrophoretic mobility led to the identiﬁcation of mu- intensity when compared with those in the control, al-
tations on both COL7A1 alleles, for all the patients. though the intensity of the larger band was stronger
Characteristics of these mutations are shown in table 1. than that of the band of normal size. Sequencing of the
Silent nucleotide substitutions located within introns larger band showed the retention of the last 70 bases of
and distant from splice sites were also identiﬁed, and intron 2, resulting from the activation of a cryptic splice-
they are listed in table 2. acceptor site TAG within intron 2. The retained 70 bp
of intron 2 introduced a PTC (TAG) 41 bp after the
Identiﬁcation of COL7A1 Mutations cryptic splice site (ﬁg. 3b). Direct sequence analysis of
the band of normal size showed a normal sequence.Nonsense mutations.—Seven base substitutions that
introduced PTCs into the coding sequence were identi- Patient 6 was homozygous for a 847-6 del5 mutation
that removed nucleotides 02 to 06 from the splice-ac-ﬁed, four of which were novel mutations (table 1). Pa-
tients 8 and 12 had a CrT transition at CGA arginine ceptor sequence of intron 6, introducing a T at the invari-
/ 9a35$$se01 08-28-97 18:45:27 ajhgal UC-AJHG
603Hovnanian et al.: COL7A1 Mutations in Epidermolysis Bullosa
Table 1
Characteristics of COL7A1 Mutations in 15 Unrelated RDEB Patients
Type VII
Name of Protein COL7A1 Collagen Veriﬁcation
Patienta Mutationb,c Nucleotide Changec Consequence Location Domaind mRNAe Proteinf Method
1
520del7 GGGATCAAGrGG Frameshift Exon 5 CMP 0 0 Sau3AI, MboI
Q281X 841CrT Nonsense Exon 6 FNIII-1A Fnu4HI
682/1GrA CTCgtrCTCat Altered splicingg Intron 5 CMP/FNIII-1A 0 0 BspHI
2
R578Xh 1732CrT Nonsense Exon 13 FNIII-4B XhoI
3 i,j 325insCG GAGrGCGAG Frameshift Exon 3 CMP / 0 BspWI
(homozygous)
4 j id. GAGrGCGAG Frameshift Exon 3 CMP 0 0 BspWI
5i 267-3CrG cagGArgagGA Altered splicingg Intron 2 CMP / 0 Sequencing
(homozygous)
6 i 847-6del5 tgggcagGTrtgGT Altered splicingg Intron 6 FNIII-1B 0 0 BspMI
(homozygous)
6527insC CCTGGrCCCTGG Frameshift Exon 80 Collagenous 0 0 BglI
7
7930-1GrC agGGAracGGA Altered splicingg Intron 106 Collagenous PstI
8
R185X 553 CrT Nonsense Exon 5 CMP ND //// Sequencing
G1982W 5944 GrT Missense Exon 72 Collagenous StyI
9
R236Xk 706 CrT Nonsense Exon 6 FNIII-1A ND //// NlaIII
R2063G 6187 CrG Missense Exon 74 Collagenous Sequencing
R1343Xk 4027 CrT Nonsense Exon 34 Collagenous // //// TaqI
10
G2049E 6146 GrA Missense Exon 73 Collagenous DdeI
G2049E 6146 GrA Missense Exon 73 Collagenous // //// DdeI
11l
G2216X 6646 GrT Nonsense Exon 83 Collagenous NlaIII
G2025A 6074 GrC Missense Exon 73 Collagenous // /// BsiYI
12
R2610X 7828 CrT Nonsense Exon 105 Collagenous DdeI
13i R2008G 6072 CrG Missense Exon 73 Collagenous /// //// BsiEI
(homozygous)
14i,l R2063W 6187 CrT Missense Exon 74 Collagenous /// /// Sequencing
(homozygous)
15 G2575R 7723 GrA Missense Exon 103 Collagenous /// ND MspI
(homozygous)
a All are affected with HS-RDEB, except for patients 9 and 12, who are affected with inverse RDEB and RDEB mitis, respectively.
b Codons are numbered according to the COL7A1 cDNA sequence published by Christiano et al. (1994b ) (GenBank L02870).
c Nucleotides are numbered according to the COL7A1 cDNA sequence published by Christiano et al. (1994b ) (GenBank L02870). Bases within exons are
denoted by uppercase letters; bases within introns are denoted by lowercase letters; and altered bases are underlined.
d CMP Å cartilage matrix–protein motif; and FNIII Å ﬁbronectin type III–like domain.
e Investigated by northern blot analysis (see ﬁg. 4).
f Analyzed by immunoﬂuorescence of skin biopsy, with LH7:2 antibody to type VII collagen (see ﬁg. 5). 0 Å Undetectable; //// Å reduced; /// Å normal;
and ND Å not determined.
g Effects on splicing are described in ﬁgure 3.
h Reported in different patients by Dunnill et al. (1994b, 1996).
i Known consanguinity.
j Two patients share same mutation and haplotype.
k Reported in the same patient by Hovnanian et al. (1994).
l Patient’s siblings have the same mutation.
ant position02. The analysis of RT-PCR products showed lane 7). Direct sequencing of band c showed a normal
sequence, whereas sequencing of band d revealed theno band of normal size but did show a band of slightly
smaller size, whose intensity was reduced when compared skipping of exon 107, which predicts the in-frame dele-
tion of 18 codons (G2644–M2661) (ﬁg. 3d). Sequencewith that in the control (ﬁg. 2, lane 6). Sequence analysis
of this band revealed the removal of the ﬁrst 13 bases of analysis of bands a and b showed heteroduplexes com-
posed of the normal COL7A1 cDNA sequence and ofexon 7, which should originate from the activation of a
cryptic splice-acceptor site CAG within exon 7. The re- a sequence with retention of the entire intron 106. Re-
tention of intron 106 predicted a TGA stop codon 251sulting frameshift created a PTC at a TGA codon 40 bp
downstream of codon 282 (ﬁg. 3c). bp after codon 2643 (ﬁg. 3d).
Mutations resulting in amino acid substitutions.—Patient 7 had a GrC change at the 01 position of
the acceptor site of intron 106 (7930-1GrC). RT-PCR Seven single-nucleotide changes leading to different
amino acid substitutions were found in eight patients,products from this patient showed four bands: a smaller
band (band d) and two larger bands (bands a and b), in mutation G2049E being present in two unrelated pa-
tients (patients 10 and 11). These missense mutationsaddition to the band of normal size (band c) (ﬁg. 2,
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Table 2
Novel COL7A1 Polymorphisms Identiﬁed in Present Study
FREQUENCY OF RARER
ALLELE
DISTANCE TO
NEAREST EXON SCREENING Patients
NAMEa LOCATION SEQUENCE (bp) METHOD (n Å 18) (n Å 50)
9712GrA intron 17 accctg(g/a)ccagct /14/exon 17 ScrF I .05 .18
17761TrC intron 51 gagtca(t/c)ggcggg /26/exon 51 NlaIII .11 .02
23946CrT intron 75 cttagt(c/t)ctgtga /25/exon 75 CSGE .27 .12
30344CrA intron 103 cctggg(c/a)cctggc 096/exon 104 AvaII .05 .30
31430CrT intron 108 acatga(c/t)agggag /30/exon 108 CSGE .05 .06
a Nucleotides are numbered according to genomic sequence in Genbank/EMBL, L23982.
changed glycine or arginine residues located within the presence in 50 unrelated controls. The presence of these
mutations was not detected in any controls tested, sug-collagenous domain of the type VII collagen molecule.
Three patients (13–15) were homozygous for mutations gesting that these changes do not correspond to rare
polymorphisms. To investigate the possibility that theseR2008G, R2063W, and G2575R, respectively, in exons
73, 74, and 103, respectively (table 1). Five other pa- defects could be associated with RDEB in other families,
we looked for their presence in 65 other RDEB patientstients were compound heterozygotes for a missense mu-
tation and a nonsense mutation: patient 8 displayed a who are currently being screened for COL7A1 muta-
tions. Mutation 682/1GrA was found in an unrelatedG1982W mutation in exon 72; patients 10 and 11
shared the same G2049E mutation in exon 73; patient patient, as was mutation R236X. Mutations R2008G
and 6527insC were identiﬁed in two and ﬁve other unre-12 affected with RDEB mitis showed a G2025A muta-
tion in exon 73; and patient 9, presenting with inverse lated RDEB patients, respectively. These ﬁnal nine pa-
tients are not included in this study, because we had noRDEB, had a R2063G mutation in exon 74 (table 1).
Interestingly, the replacement of the same arginine resi- access to their RNAs. Finally, complete screening of the
118 exons of COL7A1 in the patients whom we reportdue 2063 by a tryptophan or a glycine residue was asso-
ciated with distinct forms of the disease—that is, with
severe HS-RDEB in patient 14 and with inverse RDEB
in patient 9, respectively. All mutations occurred at resi-
dues conserved among human, hamster, and mouse
COL7A1 (Greenspan 1993; Kivirikko et al. 1996), sug-
gesting a functional importance of these residues.
Screening for the mutations.—The inheritance of the
mutations within the families studied was conﬁrmed by
either restriction-endonuclease digestion of PCR-ampli-
ﬁed DNA or automated sequencing. The possibility that
the missense mutations that we report stemmed from
polymorphic variations was tested by screening for their
Figure 3 Schematic representation of the effects of the splicing
mutations identiﬁed in RDEB patients 2 and 5–7. Exons present in
the mRNA are denoted by black boxes; exons and parts of exons
absent are denoted by hatched boxes; and novel sequences are denotedFigure 2 RT-PCR ampliﬁcation of the COL7A1 cDNA regions
encompassing exons 3–6 (patient 2), exons 2–5 (patient 5), exons 5– by gray boxes. The broken V-shaped lines designate regions of pre-
mRNA that are removed by normal splicing (N) or by abnormal8 (patient 6), and exons 102–110 (patient 7). The size (in bp) of the
bands is indicated. Bands a–d correspond to the different transcripts splicing in the patient. Cryptic splice sites used for aberrant splicing
are underlined. ‘‘Stop’’ denotes a premature-termination signal.observed in patient 7. C Å control; and M Å 100-bp ladder.
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did not reveal additional nucleotide variation predicting
an amino acid change or a splicing abnormality.
Genotype Analysis
To investigate whether the recurrence of the
325insCG and G2049E mutations, observed in families
3 and 4 and families 10 and 11, respectively, resulted
from independent events or from a common ancient
mutation, haplotype analysis was performed by use of
the microsatellite markers D3S1573 and D3S1076
ﬂanking COL7A1 (Christiano et al. 1996a). These fami-
lies were fully informative for at least one of these mark-
ers. Genotype analysis of families 3 and 4 showed that
the 325insCG mutation segregated with the same alleles
Figure 5 Type VII collagen immunostaining of skin sections byfor D31076 and D3S1573, suggesting that patients from
use of LH7:2 antibody. a, Normal control showing strong and linearthese families had inherited the same disease allele from staining of the DEJ. b, Sections from patient 5 (267-3CrG/267-
a common ancestor. This was consistent with the com- 3CrG), revealing both absence of staining and presence of a dermo/
mon geographic origin of these patients, from villages epidermal cleavage. c, Faint and discontinuous staining at the roof of
a blister in patient 13 (R2008G/R2008G). d, Strong and continuousclosely located in the northern part of Portugal. In con-
staining along the DEJ similar to the control, observed in patient 14trast, genotype analysis of families 10 and 11 showed
(R2063W/R2063W). Magniﬁcation 1 50.that the G2049E mutation segregated with different al-
leles for both markers, suggesting the occurrence of inde-
pendent events. This result was consistent with the ab-
sence of a common geographic origin for these families. ized by GAPDH hybridization. Densitometric-tracing
analysis of the COL7A1 signal:GAPDH signal ratio
Northern Blot Analysis showed a 40%–50% reduction of the COL7A1 mRNA
Northern blot analysis of RNA from keratinocytes in steady-state levels in patients 10–12 (who are com-
culture was performed on 13 patients and 2 age-matched pound heterozygotes for a nonsense and a missense mu-
controls (ﬁg. 4). Patients 1, 2, 4, 6, and 7 showed ab- tation), compared with those in their control, C2. No
sence of detectable COL7A1 mRNA. Patients 3 and 5 signiﬁcant reduction was found in patients 13–15 (who
demonstrated markedly decreased COL7A1 mRNA lev- are homozygous for a missense mutation), in compari-
els, in comparison with those in their respective controls, son with their control, C1.
C1 and C2. In contrast, patients 10–15 showed clearly
Immunolocalization of Type VII Collagendetectable COL7A1 transcripts of normal size (9.2 kb).
The quantity of RNA present in each lane was standard- Immunoﬂuorescence study.—Immunoﬂuorescence
study of skin biopsies by use of LH7:2 antibody showed
bright and linear staining along the DEJ in the control
individual (ﬁg. 5a). Staining was absent in patients 1–
7, who were homozygous or compound heterozygous
for mutations predicting PTCs (ﬁg. 5b). In contrast, pos-
itive staining at the DEJ was seen in all patients tested
who either were compound heterozygotes for a missense
and a nonsense mutation or were homozygous for a
missense mutation. Speciﬁcally, patients 8–11 and 13
showed reduced staining of the DEJ (ﬁg. 5c), and pa-
tients 12 and 14 demonstrated strong staining of inten-
Figure 4 Northern blot analysis of COL7A1 mRNA in primary sity comparable with that in the control (ﬁg. 5d) (ta-
keratinocytes from patients with RDEB and from controls. Total RNA ble 1).
(30 mg) was hybridized with a[32P]-dCTP-labeled K131 COL7A1 Standard electron microscopy and IEM.—StandardcDNA probe (Parente et al. 1991). COL7A1 mRNAs are not detect-
electron microscopy of skin biopsy showed cleavage be-able in patients 1, 2, 4, 6, and 7 and are present at extremely low
levels in patients 3 and 5 (9.2 kb). In contrast, patients 10–15 display neath the lamina densa and absence of normal AF, as
clearly detectable COL7A1 transcripts. The quantity of RNA present deﬁned by Tidman and Eady (1984), in all patients stud-
in each lane was standardized by GAPDH hybridization (lower panel). ied. Patients 10, 12, and 14 were then further studied
Patients are denoted by the same numerical designations used in table
by IEM. IEM using LH7:2 antibody showed a different1. ‘‘C1’’ and ‘‘C2’’ represent age-matched unrelated normal controls
pattern of staining in each patient. Patient 10 (R1343X/for patients 1–3 and 13–15 and for patients 4–7 and 10–12, respec-
tively. G2049E) showed absence of labeling of both the lamina
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protein detection. We conclude that the PTC-creating
mutations that we have described result in mRNA insta-
bility and absence of type VII collagen polypeptide syn-
thesis, whereas missense mutations have different effects
on protein stability and function.
Consequences of COL7A1 Mutations for Mutant
Transcripts and Protein Detection
Of the 16 patients with HS-RDEB whom we studied,
4 were homozygous for a frameshift or a splice-site mu-
tation (patients 3–6), and 3 presented different combi-
nations of nonsense, frameshift, and splice-site muta-
tions (patients 1, 2, and 7) (table 1). These mutations
gave rise to PTCs and were associated with undetectable
or drastically reduced COL7A1 transcript levels and ab-
sence of immunoreactive type VII collagen in skin. These
results support a disease mechanism involving absence
of protein synthesis, because of a PTC-mediated de-
crease in mRNA stability, as elsewhere reported for
COL7A1 and other genes (Baserga and Benz 1988; Hilal
et al. 1993; Maquat 1995). Because HS-RDEB patients
Figure 6 IEM of skin, using the LH7:2 antibody. A, Control, often demonstrate undetectable type VII collagen poly-
showing labeling of both the lower part of the lamina densa and the
peptide in the skin, it is likely that nonsense, frameshift,anchoring plaques. AF are not seen because sections were not con-
or splice-site mutations leading to PTCs are commontrasted with lead citrate and uranyl acetate (Magniﬁcation 1 4,500).
B, Skin from patient 12 reveals subnormal staining of the lamina densa causes of the most severe form of the disease. Interest-
and of the anchoring plaques comparable to the control (Magniﬁca- ingly, the splice-acceptor-site mutation identiﬁed in pa-
tion 1 9,750). LD, lamina densa; AP, anchoring plaque. tient 7 gave rise to two different splice abnormalities—
one resulting in the in-frame skipping of exon 107 and
the other resulting in retention of intron 106, which led
densa and the anchoring plaques. Patient 14 (R2063W/ to a PTC. A complex aberrant pattern of splicing re-
R2063W) showed labeling of the lamina densa, with sulting from a mutation at the second-to-last nucleotide
no staining of the anchoring plaques. Last, patient 12 of exon 3 in COL7A1 has recently been reported in a
(G2025A/R2610X) showed labeling of both the lamina patient with localized RDEB (Gardella et al. 1996). In
densa and the anchoring plaques, similar to what was the case of patient 7, the absence of detectable COL7A1
seen in the control (ﬁg. 6). Normal staining of both mRNA transcript on northern blot suggests that the
the lamina lucida and the adjacent lamina densa was principal effect of the splice-site mutation affecting in-
obtained with GB3 antibody, in patients 10, 12, and 14. tron 106 and of the 6527insC mutation is a profound
reduction in the stability of the mRNA transcripts. In
contrast, the mRNA analysis in patients 3 and 5, whoDiscussion
are homozygous for a frameshift and a splice-site muta-
tion leading to a PTC, respectively, revealed some detect-In this study, we report the characterization of
COL7A1 mutations in both alleles of 18 patients from able COL7A1 mRNA on northern blot (ﬁg. 4, patients
3 and 5, lanes 7 and 10). This could be due either to15 unrelated RDEB families. A total of 21 mutations
were identiﬁed, of which 18 had not been reported pre- unequal application of RNA, as indicated after normal-
ization for GAPDH for patient 3, or to variable degrada-viously. Of the nine mutations detected by DGGE, seven
could also be disclosed by CSGE, whereas mutations tion of the unstable mRNA. In the case of patient 5,
mutation 267-3CrG substitutes a purine residue for aQ281X (CrT at 841) and 267-3CrG did not produce
detectable shift on CSGE. This is consistent with the pyrimidine, at position 03 of a splice-acceptor site, a
position that, in vertebrates, is most often (frequencyefﬁciency of mutation detection by CSGE, which is esti-
mated to be on the order of 80%, whereas DGGE using 97%) occupied by a pyrimidine (Shapiro and Senapathy
1987). This mutation allows for some normal splicingGC clamp is thought to permit detection of 100% of
nucleotide variations (Prosser 1993). Eleven (61%) of to occur, as shown by the presence of a reduced amount
of normal COL7A1 transcripts after RT-PCR (ﬁg. 2,the 18 novel mutations predicted premature termination
of translation, and 7 were missense mutations, as sum- lane 5), which may account for the faint COL7A1 signal
seen on the northern blot.marized in table 1. We investigated the consequences
of these mutations for type VII collagen transcript and The other RDEB patients who were studied (nine pa-
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tients with HS-RDEB, one patient with RDEB mitis, and tope within the NC1 domain (Tanaka et al. 1994), it is
unlikely that these mutations, which are located withinone patient with inverse RDEB) either were homozygous
for a missense mutation (patients 13–15) or were com- the collagenous domain of the molecule, alter LH7:2
binding. Alternatively, missense mutations associatedpound heterozygotes for a nonsense and a missense mu-
tation (patients 8–12) (table 1). Several glycine-to-argi- with deﬁcient type VII collagen expression may disrupt
structural domains of the molecule whose integrity isnine substitutions acting in a recessive manner have
recently been reported in HS-RDEB and in RDEB mitis important for protein stability, as previously described
for missense mutations in other genes, such as the dys-(Christiano et al. 1996b, 1996c). Four of the missense
mutations that we report also change glycine residues trophin gene, the b-sarcoglycan gene, and the factor XIII
gene (Prior et al. 1993; Bo¨nnemann et al. 1996; Mikkolain the collagenous domain of the molecule, whereas
three other mutations change arginine residues. All of et al. 1996). In contrast, COL7A1 mutations associated
with normal immunodetection of type VII collagenthese mutations, with the exception of G2025A, are
nonconservative and result in a change of evolutionarily would lead to the synthesis, the secretion, and the depo-
sition, at the DEJ, of mutated molecules unable to assem-conserved amino acids. Speciﬁcally, mutations G2049E,
G2575R, and G1982W disrupt the repetitive Gly-X-Y ble into functional AF. This suggests that these amino
acids are located in domains of the molecule that aresequence characteristic of collagens, either by replacing
a glycine residue with a charged residue or by introduc- critical for the proper function of the type VII collagen
protein. Interestingly, the R2008G mutation that we de-ing a bulky chain in the center of the triple helix. Muta-
tions R2008G, R2063G, and R2063W result either in scribe in patient 13 occurs in an RGD (arg-gly-asp) se-
quence, which is a potential cell-attachment motif. Thus,the loss of an ionic charge or in the introduction of a
bulky chain at external positions of the triple helix. in addition to its potential effect on AF formation, this
mutation may impair the interaction between AF andThese substitutions cosegregate with the disease pheno-
type in the families and were not observed in 100 normal extracellular components such as ﬁbronectin.
We suggest that the missense mutations that we de-chromosomes in unrelated healthy individuals. There-
fore, it is unlikely that these changes represent polymor- scribe alter homotrimer formation and/or higher-or-
dered ﬁbril assembly in homozygotes and in compoundphisms.
Northern blot analysis in patients homozygous for a heterozygotes. Because heterozygous carriers are unaf-
fected, the mechanisms of action of these mutationsmissense mutation (patients 13–15) showed no signiﬁ-
cant reduction of COL7A1 transcript levels, in agree- would be distinct from the dominant-negative effect of
other glycine substitutions reported in dominant DEB.ment with the observation that missense mutations do
not usually alter mRNA stability. Patients who were The reasons why some glycine substitutions result in
dominant DEB, whereas others act in a recessive man-compound heterozygotes for a nonsense and a missense
mutation (patients 10–12) showed a reduction, by ap- ner, are unclear. However, these mutations occur at dif-
ferent glycine residues within the 19 different collage-proximately half, of the COL7A1 signal:GAPDH signal
ratio, which is consistent with a decreased stability of nous subdomains of the molecule. It is thus possible that
these amino acids are located within motifs of differentthe mutated allele bearing the nonsense mutation. Im-
munodetection of type VII collagen polypeptide in skin importance for protein processing, folding, stability, and
function of type VII collagen polypeptide.biopsies from these patients showed a normal pattern
in patients 12 and 14 and showed reduced staining in
Distribution of COL7A1 Mutationspatients 10, 11, and 13 (table 1). In all cases, electron
microscopy showed absence of identiﬁable AF. Collec- Analysis of the distribution of the COL7A1 mutations
reported here shows that six of the seven missense muta-tively, these results suggest that the missense mutations
that we report lead to the synthesis of type VII collagen tions are located within exon 72, exon 73, or exon 74,
within a region encompassing 82 amino acids next topolypeptide with decreased stability and/or altered func-
tion, resulting in impaired AF formation. the hinge region. The apparent ‘‘clustering’’ of these
mutations just after the major interruption of the collag-
Proposed Mechanism of Action of Recessive COL7A1 enous domain, a region thought to be involved in ﬂexi-
Missense Mutations bility of the molecule, may be of biological relevance.
However, mutational analysis of additional patients isIn the absence of a model for recessive collagen disor-
ders, the precise consequences of these mutations for required in order to determine whether it represents a
region prone to mutations.type VII collagen polypeptide remain speculative. How-
ever, our results suggest that some of the COL7A1 mis-
Genotype-Phenotype Correlations and Variability ofsense mutations either decrease the stability or alter anti-
the Disease for the Same Mutationgenic properties of type VII collagen, whereas others
allow for the synthesis of stable but nonfunctional poly- Genotype-phenotype analysis showed that, of the ﬁve
patients who were compound heterozygotes for a mis-peptide. Because the LH7:2 antibody recognizes an epi-
/ 9a35$$se01 08-28-97 18:45:27 ajhgal UC-AJHG
608 Am. J. Hum. Genet. 61:599–610, 1997
trat 4U002B), and the United States Public Health Service,sense mutation and a mutation leading to a PTC (pa-
National Institutes of Health (grant PO1-AR38923). A.H.tients 8–12), three were affected with severe RDEB (pa-
held a Wellcome Trust and an EEC research fellowship (con-tients 8, 10, and 11), one presented with RDEB mitis
trat BMH1-CT-94-6383). C.A.R. was supported by a DEBRA(patient 12), and another had inverse RDEB (patient 9).
UK studentship. E.P. holds a Fondation of France TelecomBecause PTCs are likely to lead to the absence of protein
fellowship. A.M.C. was a recipient of the Society for Investiga-
synthesis, owing to mRNA instability, these patients are tive Dermatology Career Development Award from the Der-
expected to express only the mutated allele bearing the matology Foundation.
missense mutation. The difference in the phenotype
would thus depend on the nature and/or position of the Referencesamino acid substitution and, possibly, on differences in
genetic background and external factors. In that con- Al-Imara L, Richards AJ, Eady RAJ, Leigh IM, Farrall M,
Pope FM (1992) Linkage of autosomal dominant dystrophictext, it is of interest that the R2063G and R2063W
epidermolysis bullosa in three British families to the markermutations, which occurred at the same arginine 2063
D3S2 close to the COL7A1. J Med Genet 29:381–382residue in patients 9 and 14, respectively, were associ-
Baserga SJ, Benz EJ (1988) Nonsense mutations in the humanated with inverse RDEB and HS-RDEB, respectively,
b-globin gene affect mRNA metabolism. Proc Natl Acad Scisuggesting that the nature of the amino acid change for
85:2056–2060a given position within the molecule may inﬂuence the
Bo¨nnemann CG, Passos-Bueno MR, McNally EM, Vainzof
phenotype. M, de Sa´ Moreira E, Marie SK, Pavanello RCM, et al (1996)
Finally, the severity of the disease differed between Genomic screening for b-sarcoglycan gene mutations: mis-
patients showing the same mutation. Speciﬁcally, pa- sense mutations may cause severe limb-girdle muscular dys-
tients 3 and 4 (20 and 8 years of age, respectively), who trophy type 2E (LGMD 2E). Hum Mol Genet 5:1953–1961
were from unrelated families, were homozygous for the Bruckner-Tuderman L (1993) Epidermolysis bullosa. In:
Royce PM, Steinmann B (eds) Connective tissue and its heri-same 325insCG mutation, but severe dysphagia was
table disorders: molecular, genetic and medical aspects. Wi-noted in patient 4 only. The disease phenotype also
ley-Liss, New York, pp 507–532showed considerable variability among affected family
Bruckner-Tuderman L, Mitsuhashi Y, Schnyder UW, Brucknermembers. The oldest affected brother in family 14 (16
P (1989) Anchoring ﬁbrils and type VII collagen are absentyears of age) presented with severe mittenlike deformi-
from skin in severe recessive dystrophic epidermolysis bul-ties of the hands at the age of 8 years, whereas his two
losa. J Invest Dermatol 93:3–9
younger affected brothers (11 and 4 years of age) did Bruckner-Tuderman L, Niemi KM, Kero M, Schnyder UW,
not develop syndactyly. Similarly, the young affected sib Reunala T (1990) Type VII collagen is expressed but anchor-
(12 years of age) from family 11 showed severe fusion ing ﬁbrils are defective in dystrophic epidermolysis bullosa
of the ﬁngers, whereas her older sister (25 years of age) inversa. Br J Dermatol 122:383–390
did not. These observations illustrate inter- and intra- Bruckner-Tuderman L, Nilssen Ø, Zimmermann DR, Dours-
Zimmermann MT, Kalinke DU, Gedde-Dahl T, Winberg J-familial phenotypic variability occurring for the same
O (1995) Immunohistochemical and mutation analysesmutation and underscore the role of genetic back-
demonstrate that procollagen VII is processed to collagengrounds and/or environmental factors in expressivity of
VII through removal of the NC-2 domain. J Cell Biol 131:the disease.
551–559Our results further illustrate the extensive diversity of
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epidermolysis bullosa. J Invest Dermatol 101:252–255
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extraction. Anal Biochem 162:156–159
Christiano AM, Anhalt G, Gibbons S, Bauer EA, Uitto J
(1994a) Premature termination codons in the type VII colla-Acknowledgments
gen gene (COL7A1) underlie severe, mutilating recessive
dystrophic epidermolysis bullosa. Genomics 21:160–168We would like to thank the RDEB families, for participating
in this study, and Simone Ormsby and Jean-Paul Monnet, for Christiano AM, D’Alessio M, Paradisi M, Angelo C, Mazzanti
C, Puddu P, Uitto J (1996a) A common insertion intechnical assistance. This work was supported by grants from
the Dystrophic Epidermolysis Bullosa Research Association COL7A1 in two Italian families with recessive dystrophic
epidermolysis bullosa. J Invest Dermatol 106:679–684(DEBRA; U.K.), The Wellcome Trust, the European Economic
Community Biomed program, the Epidermolyse Bulleuse En- Christiano AM, Greenspan DS, Hoffman GG, Zhang X, Ta-
mai Y, Lin AN, Dietz HC, et al (1993) A missense mutationtraide Association (France), the French Ministry of Health
(programme hospitalier de recherche clinique AOB94016), the in type VII collagen in two affected siblings with recessive
dystrophic epidermolysis bullosa. Nat Genet 4:62–66Institut National de la Sante´ et de la Recherche Me´dicale (con-
/ 9a35$$se01 08-28-97 18:45:27 ajhgal UC-AJHG
609Hovnanian et al.: COL7A1 Mutations in Epidermolysis Bullosa
Christiano AM, Greenspan DS, Lee S, Uitto J (1994b) Cloning Dunnill MGS, Richards AJ, Milana G, Mollica F, Eady RA,
Pope FM (1994b) A novel homozygous point mutation inof human type VII collagen: complete primary sequence of
the a1(VII) chain and identiﬁcation of intragenic polymor- the collagen VII gene (COL7A1) in two cousins with reces-
sive dystrophic epidermolysis bullosa. Hum Mol Genet 3:phisms. J Biol Chem 269:20256–20262
Christiano AM, Hoffman GG, Chung-Honet LC, Seungbok 1693–1694
Eady RAJ (1985) Transmission electron microscopy. In: Sker-L, Wen C, Uitto J, Greenspan DS (1994c) Structural organi-
zation of the human type VII collagen gene (COL7A1), com- row D, Skerrow C (eds) Methods in skin research. John
Wiley, London, pp 1–36posed of more exons than any previously characterized gene.
Genomics 21:169–179 Fine JD, Bauer EA, Briggaman RA, Carter DM, Eady RA,
Esterly NB, Holbrook KA, et al (1991) Revised clinical andChristiano AM, Hoffman GG, Zhang X, Xu Y, Tamai Y,
Greenspan DS, Uitto J. A strategy for identiﬁcation of se- laboratory criteria for subtypes of inherited epidermolysis
bullosa: a consensus report by the subcommittee on diagno-quence variants in COL7A1, and a novel 2 bp deletion mu-
tation in recessive dystrophic epidermolysis bullosa. Hum sis and classiﬁcation of the National Epidermolysis Bullosa
Registry. J Am Acad Dermatol 24:119–135Mutat (in press)
Gammon WR, Abernethy ML, Padilla KM, Prisayanh PS,Christiano AM, Lee JY-Y, Chen WJ, LaForgia S, Uitto J
Cook ME, Wright J, Briggaman RA, et al (1992) Noncollag-(1995a) Pretibial epidermolysis bullosa: genetic linkage to
enous (NC1) domain of collagen VII resembles multidomainCOL7A1 and identiﬁcation of a glycine-to-cysteine substitu-
adhesion proteins involved in tissue-speciﬁc organization oftion in the triple-helical domain of type VII collagen. Hum
extracellular matrix. J Invest Dermatol 99:691–696Mol Genet 4:1579–1583
Ganguly A, Rock MJ, Prockop DJ (1993) Conformation-sensi-Christiano AM, McGrath JA, Tan KC, Uitto J (1996b) Glycine
tive gel electrophoresis for rapid detection of single-basesubstitutions in the triple-helical region of type VII collagen
differences in double-stranded PCR products and DNA frag-result in a spectrum of dystrophic epidermolysis bullosa phe-
ments. Proc Natl Acad Sci USA 90:10325–10329notypes and patterns of inheritance. Am J Hum Genet 58:
671–681 Gardella R, Belletti L, Zoppi N, Marini D, Barlati S, Colombi
M (1996) Identiﬁcation of two splicing mutations in theChristiano AM, McGrath JA, Uitto J (1996c) Inﬂuence of the
collagen type VII gene (COL7A1) of a patient affected bysecond COL7A1 mutation in determining the phenotype
the localisata variant of recessive dystrophic epidermolysisseverity of recessive dystrophic epidermolysis bullosa. J In-
bullosa. Am J Hum Genet 59:292–300vest Dermatol 106:766–770
Greenspan DS (1993) The carboxy-terminal half of type VIIChristiano AM, Morricone A, Paradisi M, Angelo C, Mazzanti
collagen, including the non-collagenous NC-2 domain andC, Cavalieri R, Uitto J (1995b) A glycine-to-arginine substi-
intron/exon organization of the corresponding region of thetution in the triple-helical domain of type VII collagen in a
COL7A1 gene. Hum Mol Genet 2:273–278family with dominant dystrophic epidermolysis bullosa. J
Invest Dermatol 104:438–440 Heagerty AHM, Kennedy AR, Leigh IM, Purkis P, Eady RAJ
(1986) Identiﬁcation of an epidermal basement membraneChristiano AM, Rosenbaum LM, Chung-Honet LC, Parente
defect in recessive forms of dystrophic epidermolysis bullosaMG, Woodley DT, Pan T-C, Zhang RZ, et al (1992) The
by LH7:2 monoclonal antibody: use in diagnosis. Br J Der-large non-collagenous domain (NC-1) of type VII collagen is
matol 115:125–131amino-terminal and chimeric: homology to cartilage matrix
protein, the type III domains of ﬁbronectin and the A do- Hilal H, Rochat A, Duquesnoy P, Blanchet-Bardon C, Wechs-
ler J, Martin N, Christiano AM, et al (1993) A homozygousmains of von Willebrand factor. Hum Mol Genet 1:475–
481 insertion-deletion in the type VII collagen gene (COL7A1)
in Hallopeau-Siemens dystrophic epidermolysis bullosa. NatChristiano AM, Ryyna¨nen M, Uitto J (1994d) Dominant dys-
Genet 5:287–293trophic epidermolysis bullosa: identiﬁcation of a glycine-to-
serine substitution in the triple-helical domain of type VII Hovnanian A, Christiano AM, Uitto J (1993) The molecular
genetics of dystrophic epidermolysis bullosa. Arch Dermatolcollagen. Proc Natl Acad Sci USA 91:3549–3553
129:1566–1570Christiano AM, Suga Y, Greenspan DS, Ogawa H, Uitto J
(1995c) Premature termination codons on both alleles of Hovnanian A, Duquesnoy P, Blanchet-Bardon C, Knowlton
RG, Amselem S, Lathrop M, Dubertret L, et al (1992) Ge-the type VII collagen gene (COL7A1) in three brothers with
recessive dystrophic epidermolysis bullosa. J Clin Invest 95: netic linkage of recessive dystrophic epidermolysis bullosa
to the type VII collagen gene. J Clin Invest 90:1032–10361328–1334
Church GM, GilbertW (1984) Genomic sequencing. Proc Natl Hovnanian A, Hilal L, Blanchet-Bardon C, de Prost Y, Chris-
tiano AM, Uitto J, Goossens M (1994) Recurrent nonsenseAcad Sci USA 81:1991–1995
mutations within the type VII collagen gene in patients withDunnill MGS, McGrath JA, Richards AJ, Christiano AM,
severe recessive dystrophic epidermolysis bullosa. Am JUitto J, Pope FM, Eady RAJ (1996) Clinicopathological
Hum Genet 55:289–296correlations of compound heterozygous COL7A1 mutations
in recessive dystrophic epidermolysis bullosa. J Invest Der- Kivirikko S, Li K, Christiano AM, Uitto J (1996) Cloning of
mouse type VII collagen reveals evolutionary conservationmatol 107:171–177
of functional protein domains and genomic organization. JDunnill MGS, Richards AJ, Milana G, Mollica F, Atherton
Invest Dermatol 106:1300–1306D, Winship I, Farrell M, et al (1994a) Genetic linkage to
the type VII collagen gene in 26 families with generalised Leigh IM, Eady RAJ, Heagerty AHM, Purkis PE, Whitehead
PA, Burgeson RE (1988) Type VII collagen is a normalrecessive dystrophic epidermolysis bullosa and anchoring
ﬁbril abnormalities. J Med Genet 31:745–748 component of epidermal basement membrane, which shows
/ 9a35$$se01 08-28-97 18:45:27 ajhgal UC-AJHG
610 Am. J. Hum. Genet. 61:599–610, 1997
altered expression in recessive dystrophic epidermolysis bul- Rochat A, Kobayashi K, Barrandon Y (1994) Location of stem
losa. J Invest Dermatol 90:639–642 cells of human hair follicles by clonal analysis. Cell 76:
Lerman LS, Silverstein K (1987) Computational simulation of 1063–1073
DNA melting and its application to denaturing gradient gel Rusenko KW, Gammon WR, Fine JD, Briggamann RA (1989)
electrophoresis. In: Wu R (ed) Methods in enzymology. Aca- The carboxy-terminal domain of type VII collagen is present
demic Press, New York, pp 482–501 at the basement membrane in recessive dystrophic epider-
Maquat LE (1995) When cells stop making sense: effect of molysis bullosa. J Invest Dermatol 92:623–627
non-sense codons on RNA metabolism in vertebrate cells. Ryyna¨nen M, Knowlton RG, Parente MG, Chung LC, Chu
RNA 1:453–465 M-L, Uitto J (1991) Human type VII collagen: genetic link-
McGrath JA, Ishida-Yamamoto A, O’Grady A, Leigh IM, age of the gene (COL7A1) on chromosome 3 to dominant
Eady RAJ (1993) Structural variations in anchoring ﬁbrils dystrophic epidermolysis bullosa. Am J HumGenet 49:797–
in dystrophic epidermolysis bullosa: correlation with type 803
VII collagen expression. J Invest Dermatol 100:366–372 Shapiro MB, Senapathy P (1987) RNA splice junctions of dif-
Mikkola H, Yee VC, Syrja¨la¨ M, Seitz R, Egbring R, Petrini P, ferent classes of eukaryotes: sequence statistics and func-
Ljung R, et al (1996) Four novel mutations in deﬁciency tional implications in gene expression. Nucleic Acids Res
of coagulation factor XIII: consequences to expression and 15:7155–7174
structure of the A-subunit. Blood 87:141–151 Shefﬁeld VC, Cox DR, Lerman LS, Myers RM (1989) Attach-
Myers RM, Maniatis T, Lerman LS (1987) Detection and lo- ment of a 40-base-pair G/C-rich sequence (GC-clamp) to
calization of single base changes by denaturing gradient gel genomic DNA fragments by the polymerase chain reaction
electrophoresis. In: Wu R (ed) Methods in enzymology. Aca- results in improved detection of single-base changes. Proc
demic Press, New York, pp 501–527 Natl Acad Sci USA 86:232–236
Naeyaert JM, Nuytinck L, De Bie S, Beele H, Kint A, De Paepe Shimizu H, McGrath JA, Christiano AM, Nishikawa T, Uitto
A (1995) Genetic linkage between the collagen type VII gene J (1996) Molecular basis of recessive dystrophic epidermoly-
COL7A1 and pretibial epidermolysis bullosa with lichenoid sis bullosa: genotype/phenotype correlation in a case of
features. J Invest Dermatol 104:803–805
moderate clinical severity. J Invest Dermatol 106:119–124
Parente MG, Chung LC, Ryyna¨nen J, Woodley DT, Wynn
Tanaka T, Takahashi K, Furukawa F, Imamura S (1994) The
KC, Bauer EA, Mattei M-G, et al (1991) Human type VII
epitope for anti-type VII collagen monoclonal antibodycollagen: cDNA cloning and chromosomal mapping of the
(LH7:2) locates at the central region of the N-terminal non-gene. Proc Natl Acad Sci USA 88:6931–6935
collagenous domain of type VII collagen. Br J Dermatol 131:Prior TW, Papp AC, Snyder PJ, Burghes AHM, Bartolo C,
472–476Sedra MS, Western LM, et al (1993) A missense mutation
Tidman MJ, Eady RAJ (1984) Ultrastructural morphometryin the dystrophin gene in a Duchenne muscular dystrophy
of normal human dermal-epidermal junction: the inﬂuencepatient. Nat Genet 4:357–360
of age, sex, and body region on laminar and non-laminarProsser J (1993) Detecting single-base mutations. Trends Bio-
components. J Invest Dermatol 83:448–453Techniques 11:238–246
Uitto J, Christiano AM (1994) Molecular basis of the dystro-Prost C, Dubertret L, Fosse M, Wechsler J, Touraine R (1984)
phic forms of epidermolysis bullosa: mutations in the typeA routine immuno-electron microscopic technique for lo-
VII collagen gene. Arch Dermatol Res 287:16–22calizing an auto-antibody on epidermal basement mem-
Uitto J, Hovnanian A, Christiano AM (1995) Premature termi-brane. Br J Dermatol 110:1–7
nation codon mutations in the type VII collagen geneRheinwald JG, Green H (1975) Serial cultivation of strains of
(COL7A1) underlie severe recessive dystrophic epidermoly-human epidermal keratinocytes: the formation of keratiniz-
ing colonies from single cells. Cell 6:331–334 sis bullosa. Proc Assoc Am Phys 107:245–252
/ 9a35$$se01 08-28-97 18:45:27 ajhgal UC-AJHG
